Skip to content

Transvaginal Versus Transabdominal Specimen Extraction for Robotic Right-side Colon Cancer Surgery:A Single-center Randomized Control Trial

Transvaginal Versus Transabdominal Specimen Extraction for Robotic Right-side Colon Cancer Surgery:A Single-center Randomized Control Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070032
Enrollment
Unknown
Registered
2023-03-31
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Right-sided colon cancer

Interventions

A:transvaginal specimens extraction
B:transabdominal specimens extraction

Sponsors

the First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. age 18-80 years. 2. ECOG score = 2. 3. histologically or cytologically confirmed adenocarcinoma of the right hemicolectum. 4. preoperative stage: T1-3N0M0. 5. 3 to 5 cm circumferential diameter of the specimen for transvaginal NOSES. 6. preoperative examination not suggestive of metastasis or implantation, invasion of adjacent organs. 7. cardiopulmonary, hepatic, and renal function capable of tolerating the procedure. 8. Sign the informed consent form. 9. Patients with transvaginal NOSES without fertility needs

Exclusion criteria

Exclusion criteria: 1. patients who are not suitable for robotic laparoscopic surgery 2. tumours too large to be dragged out vaginally 3. Patients who are overly obese, with a BMI = 35 kg/m2 4. Excessive hypertrophy of the right hemicolectomy, which makes transvaginal extraction difficult. 5. simultaneous multiple primary cancers. 6. tumour causing intestinal obstruction or perforation 7. history of severe mental illness. 8. Combined acute gynaecological infections, vaginal malformations or unmarried infertile women and married women planning to have another child.

Design outcomes

Primary

MeasureTime frame
Pain evaluation;

Secondary

MeasureTime frame
Quality of life;Postoperative stress response and immune function status;Positive rate of tumor cells and bacterial culture;Scar evaluation;Sexual function evaluation;Complication rate during surgery and within 30 days after surgery;Mortality during hospitalization or within 30 days after surgery;Evaluation of recovery situation;days in hospital after surgery;Direct costs during hospitalization;Quality of the surgical specimens and the postoperative pathology;

Countries

China

Contacts

Public ContactTaiyuan Li

the First Affiliated Hospital of Nanchang University

jylitaiyuan@sina.com13970031518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026